ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2020.0.247 2020.0.247 2021-03-312021-03-3142020-04-01falseNo description of principal activity4falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 06753472 2020-04-01 2021-03-31 06753472 2019-04-01 2020-03-31 06753472 2021-03-31 06753472 2020-03-31 06753472 2019-04-01 06753472 c:Director4 2020-04-01 2021-03-31 06753472 d:Buildings d:LongLeaseholdAssets 2020-04-01 2021-03-31 06753472 d:Buildings d:LongLeaseholdAssets 2021-03-31 06753472 d:Buildings d:LongLeaseholdAssets 2020-03-31 06753472 d:OfficeEquipment 2020-04-01 2021-03-31 06753472 d:OfficeEquipment 2021-03-31 06753472 d:OfficeEquipment 2020-03-31 06753472 d:OfficeEquipment d:OwnedOrFreeholdAssets 2020-04-01 2021-03-31 06753472 d:OwnedOrFreeholdAssets 2020-04-01 2021-03-31 06753472 d:CurrentFinancialInstruments 2021-03-31 06753472 d:CurrentFinancialInstruments 2020-03-31 06753472 d:Non-currentFinancialInstruments 2021-03-31 06753472 d:Non-currentFinancialInstruments 2020-03-31 06753472 d:CurrentFinancialInstruments d:WithinOneYear 2021-03-31 06753472 d:CurrentFinancialInstruments d:WithinOneYear 2020-03-31 06753472 d:Non-currentFinancialInstruments d:AfterOneYear 2021-03-31 06753472 d:Non-currentFinancialInstruments d:AfterOneYear 2020-03-31 06753472 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2021-03-31 06753472 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2020-03-31 06753472 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2021-03-31 06753472 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2020-03-31 06753472 d:ShareCapital 2021-03-31 06753472 d:ShareCapital 2020-03-31 06753472 d:CapitalRedemptionReserve 2021-03-31 06753472 d:CapitalRedemptionReserve 2020-03-31 06753472 d:RetainedEarningsAccumulatedLosses 2021-03-31 06753472 d:RetainedEarningsAccumulatedLosses 2020-03-31 06753472 c:OrdinaryShareClass1 2020-04-01 2021-03-31 06753472 c:OrdinaryShareClass1 2021-03-31 06753472 c:OrdinaryShareClass1 2020-03-31 06753472 c:FRS102 2020-04-01 2021-03-31 06753472 c:AuditExempt-NoAccountantsReport 2020-04-01 2021-03-31 06753472 c:FullAccounts 2020-04-01 2021-03-31 06753472 c:PrivateLimitedCompanyLtd 2020-04-01 2021-03-31 06753472 d:AcceleratedTaxDepreciationDeferredTax 2021-03-31 06753472 d:AcceleratedTaxDepreciationDeferredTax 2020-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 06753472










APRIS MEDICAL SERVICES LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2021

 
APRIS MEDICAL SERVICES LIMITED
REGISTERED NUMBER: 06753472

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2021

2021
2020
Note
£
£

Fixed assets
  

Tangible assets
 4 
113,587
119,742

  
113,587
119,742

Current assets
  

Stocks
  
29,517
28,985

Debtors: amounts falling due within one year
 5 
262,339
239,804

Cash at bank and in hand
 6 
271,282
138,058

  
563,138
406,847

Creditors: amounts falling due within one year
 7 
(511,639)
(343,390)

Net current assets
  
 
 
51,499
 
 
63,457

Total assets less current liabilities
  
165,086
183,199

Creditors: amounts falling due after more than one year
 8 
(67,068)
(107,196)

Provisions for liabilities
  

Deferred tax
 10 
(19,479)
(20,648)

  
 
 
(19,479)
 
 
(20,648)

Net assets
  
78,539
55,355


Capital and reserves
  

Called up share capital 
 11 
68
68

Capital redemption reserve
  
18
18

Profit and loss account
  
78,453
55,269

  
78,539
55,355


Page 1

 
APRIS MEDICAL SERVICES LIMITED
REGISTERED NUMBER: 06753472
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2021

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
Dr R M Oliver
Director


Date: 13 December 2021

The notes on pages 3 to 11 form part of these financial statements.

Page 2

 
APRIS MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021

1.


General information

Apris Medical Services Limited is a company limited by shares incorporated in England within the United Kingdom. The address of the registered office is Cromer Group Practice, Mill Road, Cromer, Norfolk, NR27 0BG.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

The directors have considered the company's position at the time of signing the finanical statements, and in particular the current issues caused by Covid-19 and it's potential impact on the company and the wider economy. As such under the current circumstances, it is difficult to produce meaningful forecasts for the remainder of the financial year and medium term. Nevertheless, the directors have considered the current financial strength of the company, together with the range of measures the directors can take to mitigate ongoing costs should they need to.

Based on this, the directors have concluded that they have a reasonable expectation that the company will have adequate resources to continue in operational existence for the foreseeable future, and based on the economic environment recovering within the timeframe currently being widely anticipated, at least twelve months for the date of signing these financial statements, they therefore continue to adopt the going concern basis of accounting in preparing these financial statements. 

Page 3

 
APRIS MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021

2.Accounting policies (continued)

 
2.3

Turnover

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Turnover from the sale of goods is recognised when all of the following conditions are satisfied:
the company has transferred the significant risks and rewards of ownership to the buyer;
the company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Operating leases: the company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the lease term.

 
2.5

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Income Statement in the same period as the related expenditure.

 
2.6

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 4

 
APRIS MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021

2.Accounting policies (continued)

 
2.7

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.8

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Statement of Financial Position date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

 
2.9

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a straight line and reducing balance basis as detailed below..

Depreciation is provided on the following basis:

Long-term leasehold property
-
5%
straight line
Office equipment
-
20%
reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 5

 
APRIS MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021

2.Accounting policies (continued)

 
2.10

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis.
At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.11

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.12

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.13

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.14

Provisions for liabilities

Provisions are made where an event has taken place that gives the company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the company becomes aware of the obligation, and are measured at the best estimate at the Statement of Financial Position date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Statement of Financial Position.

 
2.15

Financial instruments

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Page 6

 
APRIS MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021

2.Accounting policies (continued)

 
2.16

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 4 (2020 - 4).


4.


Tangible fixed assets





Long-term leasehold property
Office equipment
Total

£
£
£



Cost or valuation


At 1 April 2020
128,734
5,162
133,896


Additions
-
1,260
1,260



At 31 March 2021

128,734
6,422
135,156



Depreciation


At 1 April 2020
12,432
1,722
14,154


Charge for the year on owned assets
6,474
941
7,415



At 31 March 2021

18,906
2,663
21,569



Net book value



At 31 March 2021
109,828
3,759
113,587



At 31 March 2020
116,302
3,440
119,742

Page 7

 
APRIS MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021

5.


Debtors

2021
2020
£
£


Trade debtors
203,982
197,445

Other debtors
53,854
40,228

Prepayments and accrued income
4,503
2,131

262,339
239,804



6.


Cash and cash equivalents

2021
2020
£
£

Cash at bank and in hand
271,282
138,058

271,282
138,058



7.


Creditors: Amounts falling due within one year

2021
2020
£
£

Bank loans
39,987
39,234

Trade creditors
337,685
19,949

Corporation tax
41,300
42,191

Other creditors
88,167
236,991

Accruals and deferred income
4,500
5,025

511,639
343,390


The following liabilities were secured:

2021
2020
£
£



Bank loans
39,987
39,234

39,987
39,234

Details of security provided:

The bank loan is secured by a charge over the assets of the company.

Page 8

 
APRIS MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021

8.


Creditors: Amounts falling due after more than one year

2021
2020
£
£

Bank loans
67,068
107,196

67,068
107,196


The following liabilities were secured:

2021
2020
£
£



Bank loans
67,068
107,196

67,068
107,196

Details of security provided:

The bank loan is secured by a charge over the assets of the company.

Page 9

 
APRIS MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021

9.


Loans


Analysis of the maturity of loans is given below:


2021
2020
£
£

Amounts falling due within one year

Bank loans
39,987
39,234


39,987
39,234

Amounts falling due 1-2 years

Bank loans
41,244
40,469


41,244
40,469

Amounts falling due 2-5 years

Bank loans
25,824
66,727


25,824
66,727


107,055
146,430



10.


Deferred taxation




2021
2020


£

£






At beginning of year
(20,648)
(19,521)


Charged to profit or loss
1,169
(1,127)



At end of year
(19,479)
(20,648)

The provision for deferred taxation is made up as follows:

2021
2020
£
£


Accelerated capital allowances
(19,479)
(20,648)

(19,479)
(20,648)

Page 10

 
APRIS MEDICAL SERVICES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021

11.


Share capital

2021
2020
£
£
Allotted, called up and fully paid



68 (2020 - 68) Ordinary shares of £1.00 each
68
68




 
Page 11